{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fcroi-2024-hiv-podcast-npoWWJTW","width":444,"version":"1.0","type":"rich","title":"Key HIV Studies From CROI 2024 Influencing Clinical Practice","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/ef4b6e72-4162-4273-a0c6-a162cba5344b/6958-croi-cf-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/9eb3ad74-2219-4e1f-8e52-0065cf8357a0\" height=\"200\" width=\"100%\" title=\"Key HIV Studies From CROI 2024 Influencing Clinical Practice\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Joseph J. Eron, Jr., MD, and Monica Gandhi, MD, MPH, discuss the most clinically relevant new data presented at CROI 2024, including long-acting ART, comorbidities and coinfections, and what’s on the horizon in HIV treatment."}